Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci

Journal of Hospital Infection

Volumn 70, Issue 4, 2008, Pages 346-352

  Contreras, G A ^a,e   DiazGranados, C A ^b   Cortes, L ^a   Reyes, J ^a   Vanegas, S ^c   Panesso, D ^a   Rincon S ^a   Diaz L ^a   Prada, G ^c   Murray, B E ^d,e   Arias, C A ^a,d  

^a UNIVERSIDAD EL BOSQUE   (Colombia)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fundacion Santa Fe   (Colombia)

^d Center for the Study of Emerging and Reemerging Pathogens   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Enterococcus gallinarum; Infection control; Nosocomial infection; Outbreak; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; PROTEIN VANC1; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; EPIDEMIC; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HYBRIDIZATION; INFANT; INFECTION RISK; LENGTH OF STAY; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NONHUMAN; PARANASAL SINUS; PATHOGENESIS; PULSED FIELD GEL ELECTROPHORESIS; RARE SPECIES; SEX RATIO; TEACHING HOSPITAL; TERTIARY HEALTH CARE; URINALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLOMBIA; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; SPECIES SPECIFICITY; VANCOMYCIN; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 56249095443     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.07.012     Document Type: Article

References (23)

1. Burger T., Fry D., Fusco R., et al. Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999-2002. Am J Infect Control 34 (2006) 458-464
2. Arias C.A., Courvalin P., and Reynolds P.E. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 44 (2000) 1660-1666
3. Choi S.H., Lee S.O., Kim T.H., et al. Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases. Clin Infect Dis 38 (2004) 53-61
4. Reid K.C., Cockerill III F.R., and Patel R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 32 (2001) 1540-1546
5. de Perio M.A., Yarnold P.R., Warren J., and Noskin G.A. Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia. Infect Control Hosp Epidemiol 27 (2006) 28-33
6. Cooper M.P., Lessa F., Brems B., et al. Outbreak of Enterococcus gallinarum infections after total knee arthroplasty. Infect Control Hosp Epidemiol 29 (2008) 361-363
7. Shankar N., Baghdayan A.S., and Gilmore M.S. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature 417 (2002) 746-750
8. Nallapareddy S.R., Huang Wenxiang H., George M., Weinstock G.M., and Murray B.E. Molecular characterization of a widespread, pathogenic, and antibiotic resistance-receptive Enterococcus faecalis lineage and dissemination of its putative pathogenicity island. J Bacteriol 187 (2005) 5709-5718
9. Rice L.B., Carias L., Rudin S., et al. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187 (2003) 508-512
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Approved standard; CLSI document M100-S16 (2006), Clinical and Laboratory Standards Institute, Wayne, PA
11. Duh R.W., Sing K.V., Malathum K., and Murray B.E. In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Microb Drug Resist 7 (2001) 39-46
12. Dutka-Malen S., Evers S., and Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33 (1995) 24-27
13. Murray B.E., Singh K.V., Heath J.D., Sharma B.R., and Weinstock G.M. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 28 (1990) 2059-2063
14. Tenover F.C., Arbeit R.D., Goering V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
15. Murray B.E., Singh K.V., Ross R.P., Heath J.D., Dunny G.M., and Weinstock G.M. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J Bacteriol 175 (1993) 5216-5223
16. Horan T.C., and Gaynes R.P. Surveillance of nosocomial infections. In: Mayhall C.G. (Ed). Hospital Epidemiology and Infection Control. 3rd edn. (2004), Lippincott Williams & Wilkins, Philadelphia 1659-1702
17. Bearman G.M., and Wenzel R.P. Bacteremias: a leading cause of death. Arch Med Res 36 (2005) 646-659
18. Vergis E.N., Hayden M.K., Chow J.W., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med 135 (2001) 484-492
19. DiazGranados C.A., Zimmer S.M., Klein M., and Jernigan J.A. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41 (2005) 327-333
20. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 16 (1995) 105-113
21. Humphreys H. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?. J Hosp Infect 62 (2006) 133-135
22. Harris A.D., Carmeli Y., Samore M.H., Kaye K.S., and Perencevich E. Impact of severity of illness bias and control group misclassification bias in case-control studies of antimicrobial-resistant organisms. Infect Control Hosp Epidemiol 26 (2005) 342-345
23. Harris A.D., Samore M.H., Lipsitch M., Kaye K.S., Perencevich E., and Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 34 (2002) 1558-1563